An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.

[1]  T. Williams,et al.  The attraction of chemokines as a target for specific anti‐inflammatory therapy , 2006, British journal of pharmacology.

[2]  R. Alon,et al.  Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.

[3]  Marc Parmentier,et al.  Dimerization of chemokine receptors and its functional consequences. , 2005, Cytokine & growth factor reviews.

[4]  M. Oppermann,et al.  G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers* , 2005, Journal of Biological Chemistry.

[5]  K. Matsushima,et al.  The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. , 2005, International immunology.

[6]  J. Isaacs,et al.  A Non-Glycosaminoglycan-Binding Variant of CC Chemokine Ligand 7 (Monocyte Chemoattractant Protein-3) Antagonizes Chemokine-Mediated Inflammation1 , 2005, The Journal of Immunology.

[7]  R. Horuk,et al.  The clinical potential of chemokine receptor antagonists. , 2005, Pharmacology & therapeutics.

[8]  Silvia Sebastiani,et al.  A rich chemokine environment strongly enhances leukocyte migration and activities. , 2005, Blood.

[9]  Waldemar Kolanus,et al.  Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines , 2005, Nature Immunology.

[10]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[11]  Guoping Wu,et al.  Platelet Factor 4 and Interleukin-8 CXC Chemokine Heterodimer Formation Modulates Function at the Quaternary Structural Level* , 2005, Journal of Biological Chemistry.

[12]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[13]  M. Oppermann.  Chemokine receptor CCR5: insights into structure, function, and regulation. , 2004, Cellular signalling.

[14]  Chongguang Chen,et al.  Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. , 2004, European journal of pharmacology.

[15]  Simi Ali,et al.  Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate , 2003, Journal of Cell Science.

[16]  Simi Ali,et al.  Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? , 2003, Transplantation.

[17]  Arkadiusz Z Dudek,et al.  Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis. , 2003, Blood.

[18]  T. Rogers,et al.  Ca2+-independent Protein Kinase Cs Mediate Heterologous Desensitization of Leukocyte Chemokine Receptors by Opioid Receptors* , 2003, The Journal of Biological Chemistry.

[19]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Martin Oppermann,et al.  β-Arrestin Binding to CC Chemokine Receptor 5 Requires Multiple C-terminal Receptor Phosphorylation Sites and Involves a Conserved Asp-Arg-Tyr Sequence Motif* , 2002, The Journal of Biological Chemistry.

[21]  P. Carter.  Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? , 2002, Current opinion in chemical biology.

[22]  Martin Oppermann,et al.  Characterization of Sequence Determinants within the Carboxyl-terminal Domain of Chemokine Receptor CCR5 That Regulate Signaling and Receptor Internalization* , 2001, The Journal of Biological Chemistry.

[23]  R. Alon,et al.  Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines , 2001, Nature Immunology.

[24]  D. Kerjaschki,et al.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. , 2001, The American journal of pathology.

[25]  A. Lentsch,et al.  Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC) , 2000 .

[26]  Simi Ali,et al.  Examination of the Function of RANTES, MIP-1α, and MIP-1β following Interaction with Heparin-like Glycosaminoglycans* , 2000, The Journal of Biological Chemistry.

[27]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[28]  R. Snyderman,et al.  Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and Secretion , 1999, The Journal of Biological Chemistry.

[29]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Snyderman,et al.  Chemoattractant Receptor Cross-desensitization* , 1999, The Journal of Biological Chemistry.

[31]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[32]  R. Snyderman,et al.  Multiple Signaling Pathways of Human Interleukin-8 Receptor A , 1998, The Journal of Biological Chemistry.

[33]  James J. Campbell,et al.  Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis , 1997, The Journal of cell biology.

[34]  R. Snyderman,et al.  Cross-desensitization Among Receptors for Platelet Activating Factor and Peptide Chemoattractants , 1996, The Journal of Biological Chemistry.

[35]  R. Snyderman,et al.  Cross-desensitization of Chemoattractant Receptors Occurs at Multiple Levels , 1995, The Journal of Biological Chemistry.

[36]  D. Danilenko,et al.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.

[37]  M. Cybulsky,et al.  Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. , 1993, Journal of immunology.

[38]  M. Cybulsky,et al.  Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. , 1991, Journal of immunology.

[39]  A. M. Lefer,et al.  Cardioprotective and endothelial protective effects of [Ala‐IL8]77 in a rabbit model of myocardial ischaemia and reperfusion , 1991, British journal of pharmacology.

[40]  R. Hershkoviz,et al.  Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. , 2003, International immunology.